Paolo Gresele

Overview

Best Publications

• COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS

  R Altman;L Carreras;R Diaz;E Figueroa

  6329
  Citations

• Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome.

  Vittorio Pengo;Gentian Denas;Giacomo Zoppellaro;Seena Padayattil Jose

  805
  Citations

• Clinical course of high-risk patients diagnosed with antiphospholipid syndrome

  Vittorio Pengo;Amelia Ruffatti;C Legnani;P Gresele

  692
  Citations

• Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study.

  Vittorio Pengo;Amelia Ruffatti;Cristina Legnani;Sophie Testa

  483
  Citations

• Whole-genome sequencing of patients with rare diseases in a national health system

  Ernest Turro;William J Astle;Karyn Megy;Stefan Graf

  392
  Citations

• COVID-19 and haemostasis: a position paper from Italian Society on Thrombosis and Haemostasis (SISET).

  Marco Marietta;Walter Ageno;Andrea Artoni;Erica De Candia

  386
  Citations

• Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with type II diabetes mellitus

  Paolo Gresele;Giuseppe Guglielmini;Massimiliano De Angelis;Silvia Ciferri

  353
  Citations

• Anti-platelet therapy: phosphodiesterase inhibitors.

  Paolo Gresele;Stefania Momi;Emanuela Falcinelli

  326
  Citations

• MYH9-Related Disease: May-Hegglin Anomaly, Sebastian Syndrome, Fechtner Syndrome, and Epstein Syndrome Are not Distinct Entities but Represent a Variable Expression of a Single Illness

  Marco Seri;Alessandro Pecci;Filomena Di Bari;Roberto Cusano

  309
  Citations

• Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk: Meta-Analysis of 119 Clinical Trials Involving 100 667 Patients

  Peter Willeit;Lena Tschiderer;Elias Allara;Kathrin Reuber

  303
  Citations

• Diabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo. Evidence derived from the study of peripheral arterial disease.

  Giovanni Davı̀;Paolo Gresele;Francesco Violi;Stefania Basili

  303
  Citations

• Thromboembolic complications and haemostatic changes in cyclosporin-treated cadaveric kidney allograft recipients.

  Y. Vanrenterghem;L. Roels;T. Lerut;J. Gruwez

  297
  Citations

• Gastrointestinal Safety of NO-Aspirin (NCX-4016) in Healthy Human Volunteers:A Proof of Concept Endoscopic Study

  Stefano Fiorucci;Luca Santucci;Paolo Gresele;Roberto Maffei Faccino

  295
  Citations

• Platelet P-selectin is required for pulmonary eosinophil and lymphocyte recruitment in a murine model of allergic inflammation

  Simon C. Pitchford;Stefania Momi;Stefania Momi;Silvia Giannini;Silvia Giannini;Lucio Casali;Lucio Casali

  270
  Citations

• Platelets are essential for leukocyte recruitment in allergic inflammation.

  Simon C. Pitchford;Hiroshi Yano;Rebecca Lever;Yanira Riffo-Vasquez

  260
  Citations

• Prolonging prostacyclin production by nafazatrom or dipyridamole

  Hans Deckmyn;P Gresele;Jozef Arnout;A Todisco

  246
  Citations

• Effects of resveratrol and other wine polyphenols on vascular function: An update

  Paolo Gresele;Chiara Cerletti;Giuseppe Guglielmini;Pasquale Pignatelli

  240
  Citations

• Diagnosis of inherited platelet function disorders: guidance from the SSC of the ISTH

  P. Gresele

  231
  Citations

• Position of nonmuscle myosin heavy chain IIA (NMMHC-IIA) mutations predicts the natural history of MYH9-related disease

  Alessandro Pecci;Emanuele Panza;Núria Pujol-Moix;Catherine Klersy

  216
  Citations

• Deficiency of thrombin activatable fibrinolysis inhibitor in cirrhosis is associated with increased plasma fibrinolysis.

  Mario Colucci;Bianca M. Binetti;Maria G. Branca;Carlo Clerici

  215
  Citations